The U.S. Food and Drug Administration (FDA) has approved Bkemv (eculizumab-aeeb) as…
Invimeds HealthJune 3, 2024
Introduction: In the dynamic landscape of oncology treatment, biosimilars have emerged as…
Invimeds HealthMay 15, 2024
Introduction: In the global fight against the COVID-19 pandemic, vaccines have become…
Invimeds HealthMay 1, 2024
The FDA has approved Avzivi (bevacizumab-tnjn), the fifth biosimilar of bevacizumab developed…
Invimeds HealthJanuary 10, 2024
We're thrilled to share groundbreaking news in the realm of oncology: On…
Invimeds HealthDecember 19, 2023
The US Food and Drug Administration (FDA) has approved Wezlana (ustekinumab-auub) as…
Invimeds HealthNovember 2, 2023
Another wreath has been added to Horizon Therapeutics' pre-takeover victory lap. Months…
Invimeds HealthSeptember 1, 2023